Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of 40-Bp Deletion / Insertion Polymorphism of Mdm2 and 16-Bp Deletion / Insertion Polymorphism of P53 Gene in Patients With Lymphoma in a Persian Population Publisher



Hashemi SM1 ; Farsi A2 ; Bahari G3 ; Danesh H4 ; Roudini K5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Associate Professor of Hematology & Oncology, Department of Internal Medicine, School of Medicine, Clinical Immunology Research Center, Ali Ibne Abitaleb Hospital, Zahedan University of Medical ciences, Zahedan, Iran
  2. 2. GP, Zahedan University of Medical Sciences, Zahedan, Iran
  3. 3. Associate Professor of Clinical Biochemistry, Department of Biochemistry, School of Medicine, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran
  4. 4. Plastic, Reconstructive & Aesthetic surgeon, Assistant professor of Zahedan University of Medical Sciences, Zahedan, Iran
  5. 5. Assistant Professor of Hematology & Oncology, Department of Internal Medicine, School of Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Genetika Published:2021


Abstract

Hashemi M. S., A. Farsi, G. Bahari, H. Danesh, K. Roudini (2021). Evaluation of 40-bp deletion / insertion polymorphism of mdm2 and 16-bp deletion / insertion polymorphism of p53 gene in patients with lymphoma in a Persian population. - Genetika, Vol 53, No.3, 997-1005. Considering the importance of lymphoma and its prevalence in communities as well as its relationship with genetic factors (P53 & MDM2) as well as contradictory results about the possible role of deletion / insertion of polymorphisms in different types of cancer. The aim of this study was to investigate the deletion / insertion of 40 bp of mdm2 polymorphism and 16-bp of p53 polymorphism in patients with lymphoma. In this casecontrol study, 152 non-Hodgkin's lymphoma patients and 155 healthy individuals were selected by convenience sampling method. MDM2 and P53 polymorphisms were examined by PCR. SPSS V22 software was used to interpret the results. The results of the study showed that rs3730485 species was associated with the risk of lymphoma. The Ins / Del and Del / Del genotypes reduce the risk of lymphoma compared to the Ins / Ins genotype (OR = 0.41,95% CI = 0.25-0.65 P <0.001 and OR = 0.33.95% CI = 0.12). 0.96,P = 0.035 In relation to Ins / Del + Del / Del and Ins / Del, the results also showed that they reduce the risk of lymphoma (OR = 0.40,95% CI = 0.25-0.63, P <0.001). Results indicated that Ins / Del, Del / Del, Ins / Del + Del / Del and D alleles genotypes had a statistically significant relationship with lymphoma risk. Due to the fact that the OR genotypes of this site are less than one step away, it is a protective factor for lymphoma, so that these alleles and the mentioned genotype reduce the risk of lymphoma. © 2021. Genetika. All Rights Reseved.